Carbon Monoxide Poisoning Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia Cohort
Conditions: Neonatal Jaundice; Neonatal Hyperbilirubinemia; Hemolysis Neonatal Interventions: Diagnostic Test: End-tidal carbon monoxide-corrected (ETCOc) Sponsors: Guangzhou Women and Children ' s Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure
Conditions: Heart Failure; Pulmonary Hypertension; Pulmonary Vascular Resistance Abnormality Interventions: Diagnostic Test: non-contrast chest CT; Diagnostic Test: spirometry with diffusing lung capacity for carbon monoxide (DLCO) analysis; Diagnostic Test: Omics analysis of blood plasma obtained from pulmonary artery or peripheral blood; Diagnostic Test: supine bike exercise during right heart catheterisation; Diagnostic Test: Lung ventilation/perfusion SPECT Sponsors: Institute for Clinical and Experimental Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
Conditions: Tobacco-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Carbon Monoxide Measurement; Behavioral: Smokeless Tobacco Use; Other: Survey Administration Sponsors: Ohio State University Comprehensive Cancer Center; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Comparison of the Effectiveness of Treatments in Carbon Monoxide Intoxications
Conditions: Carbon Monoxide Poisoning Sponsors: Ankara City Hospital Bilkent Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)
Conditions: Anemia, Sickle Cell Interventions: Drug: HBI-002 Sponsors: Hillhurst Biopharmaceuticals, Inc.; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP) —a structured summary of a study protocol for a randomized controlled study
DiscussionCombining behavioural counselling and medical therapy, e.g. with varenicline, improves abstinence rates and is considered the standard of care. We expect a further increase in quit rates by adding a second component of medical therapy and assume a dual effect of dulaglutide treatment (blunting nicotine withdrawal symptomsand reducing post-cessational weight gain). This project is of high relevance as it explores novel treatment options aimed at preventing the disastrous consequences of nicotine consumption and obesity.Trial registrationClinicalTrials.govNCT03204396. Registered on June 26, 2017. (Source: Trials)
Source: Trials - April 20, 2023 Category: Research Source Type: clinical trials

The Efficacy of L-Carnitine in the Management of Acute Carbon Monoxide Poisoning
Condition: Carbon Monoxide Poisoning Intervention: Dietary Supplement: L-Carnitine Sponsor: Alexandria University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2022 Category: Research Source Type: clinical trials